Fatigue, cognitive changes and sleep disturbances were as important to patients with early Parkinson’s disease as symptoms ...

Life expectancy in patients with open spina bifida varies with the severity of impairment, mobility, feeding ability, and continence, a new cohort study suggests.

More early-stage data show the drug, called salanersen, appeared to have positive effects on neurodegeneration and motor function in patients previously treated with Novartis' Zolgensma.

Gain Therapeutics’ phase 1 drug for Parkinson’s disease associated with a common gene mutation appears to restore motor function in mice, even after a delay between symptom onset and treatment, new ...

Scientists traced connectivity between neurons to identify how the brain communicates with the spinal cord to control motor function. Signals relayed to motor neurons from the brain enable muscle ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic ...

The extension of the TOPAZ study provided support for the long-term benefits and safety of apitegromab therapy in patients with spinal muscular atrophy (SMA) at 36 months. Apitegromab is a ...

All current local anesthetics block sensory signals—pain—but they also interrupt motor signals, which can be problematic. For example, too much epidural anesthesia can prevent mothers in labor from ...